Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Epithelial cell apoptosis is a regulated cellular process vital for removing unneeded, damaged, or potentially dangerous epithelial cells. It involves two main molecular pathways: the intrinsic (mitochondrial) pathway, regulated by Bcl-2 family proteins, and the extrinsic (death receptor) pathway, mediated by receptors such as Fas and TNF receptors. Execution of apoptosis in epithelial tissues is essential for maintaining tissue integrity—dying epithelial cells signal neighbors to promote their extrusion and preserve barrier function. Dysregulation of this process is linked to disease: excessive apoptosis can lead to tissue breakdown, while defective apoptosis enables tumor development.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Epithelial cell apoptosis process.